CVS Caremark and Aetna to Cease Dexcom CGM Coverage, Mandating Switch to Abbott FreeStyle Libre 3 Plus for Some Users
Effective January 1, 2027, certain plans under CVS Caremark and Aetna will no longer cover Dexcom Continuous Glucose Monitors (CGMs) as a pharmacy benefit. This decision will require some Dexcom users to switch to Abbott’s FreeStyle Libre 3 Plus. Both Dexcom G7 and Abbott FreeStyle Libre 3 Plus are advanced CGMs that provide real-time glucose readings, track trends, and alert users to high and low glucose levels. However, there are notable differences in sensor life, data frequency, warm-up time, connectivity, and insulin pump compatibility. For instance, Dexcom G7 has a faster 30-minute warm-up time and a predictive 'Urgent Low Soon' alert, while Libre 3 Plus offers glucose readings every minute and a longer sensor wear time of 15 days compared to Dexcom's 10 days. The Diabetes Patient Advocacy Coalition (DPAC) has launched an advocacy campaign in response, urging these providers to reconsider the forced non-medical switches and protect uninterrupted access to CGM technology.